Association of estimated plasma volume status with hemodynamic and echocardiographic parameters.


Journal

Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 18 10 2019
accepted: 14 01 2020
pubmed: 2 2 2020
medline: 10 6 2021
entrez: 2 2 2020
Statut: ppublish

Résumé

Estimated plasma volume status (ePVS) has diagnostic and prognostic value in patients with heart failure (HF). However, it remains unclear which congestion markers (i.e., biological, imaging, and hemodynamic markers) are preferentially associated with ePVS. In addition, there is evidence of sex differences in both the hematopoietic process and myocardial structure/function. Patients with significant dyspnea (NYHA ≥ 2) underwent echocardiography and lung ultrasound within 4 h prior to cardiac catheterization. Patients were divided according to tertiles based on sex-specific ePVS thresholds calculated from hemoglobin and hematocrit measurements using Duarte's formula. Among the 78 included patients (median age 74.5 years; males 69.2%; HF 48.7%), median ePVS was 4.1 (percentile ePVS is associated with E/e' regardless of sex, while only associated with invasively measured left-ventricular end-diastolic pressure in females. These results suggest that ePVS is preferably associated with left-sided hemodynamic markers of congestion.

Sections du résumé

BACKGROUND BACKGROUND
Estimated plasma volume status (ePVS) has diagnostic and prognostic value in patients with heart failure (HF). However, it remains unclear which congestion markers (i.e., biological, imaging, and hemodynamic markers) are preferentially associated with ePVS. In addition, there is evidence of sex differences in both the hematopoietic process and myocardial structure/function.
METHOD AND RESULTS RESULTS
Patients with significant dyspnea (NYHA ≥ 2) underwent echocardiography and lung ultrasound within 4 h prior to cardiac catheterization. Patients were divided according to tertiles based on sex-specific ePVS thresholds calculated from hemoglobin and hematocrit measurements using Duarte's formula. Among the 78 included patients (median age 74.5 years; males 69.2%; HF 48.7%), median ePVS was 4.1 (percentile
CONCLUSION CONCLUSIONS
ePVS is associated with E/e' regardless of sex, while only associated with invasively measured left-ventricular end-diastolic pressure in females. These results suggest that ePVS is preferably associated with left-sided hemodynamic markers of congestion.

Identifiants

pubmed: 32006155
doi: 10.1007/s00392-020-01599-9
pii: 10.1007/s00392-020-01599-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1060-1069

Auteurs

Masatake Kobayashi (M)

INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.

Olivier Huttin (O)

INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.

Erwan Donal (E)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
INSERM, U1099, 35000, Rennes, France.

Kevin Duarte (K)

INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.

Arnaud Hubert (A)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
INSERM, U1099, 35000, Rennes, France.

Hervé Le Breton (H)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
INSERM, U1099, 35000, Rennes, France.

Elena Galli (E)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
INSERM, U1099, 35000, Rennes, France.

Maxime Fournet (M)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
INSERM, U1099, 35000, Rennes, France.

Philippe Mabo (P)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
INSERM, U1099, 35000, Rennes, France.

Frederic Schnell (F)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
Service de Médicine du Sport, CHU Rennes, 35000, Rennes, France.

Christophe Leclercq (C)

Service de Cardiologie Et Maladies Vasculaires Et CIC-IT 1414, CHU Rennes, 35000, Rennes, France.
Université de Rennes 1, LTSI, 35000, Rennes, France.
INSERM, U1099, 35000, Rennes, France.

Patrick Rossignol (P)

INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France.

Nicolas Girerd (N)

INSERM, Centre d'Investigations Cliniques 1433, CHRU de Nancy, Inserm 1116 and INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, Université de Lorraine, 4, rue du Morvan, 54500, Vandoeuvre-Les-Nancy, France. n.girerd@chru-nancy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH